<DOC>
	<DOCNO>NCT02272582</DOCNO>
	<brief_summary>A prospective randomize , double-blinded , comparative within-person study evaluate use SOMVC001 vs. heparin dose saline patient undergo CABG .</brief_summary>
	<brief_title>A Study Evaluate Use SOMVC001 ( GALA ) Vascular Conduit Preservation Solution Patients Undergoing CABG ( STEPS )</brief_title>
	<detailed_description>Saphenous vein ( SV ) harvesting perform use open endoscopic vein harvest technique . Once harvest , SV divide segment vein segment patient immerse one two blind solution : SOMVC001 heparin dose saline . The patient randomize SVG segment allocation define graft assigned target region . Imaging , use 64-slice well MDCT , complete 4-6 week 3 month post surgery ( CABG ) procedure .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Patient undergo primary , multivessel CABG least two saphenous vein graft ( SVGs ) Patient insitu Internal Mammary Artery graft ( ) ( IMA ) , ( SVG free arterial graft ) Patients prior CABG plan concomitant valve surgery aortic aneurysm repair .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>